Document is current
Any future updates will be listed below
-
Authors
Sawada, Akinari https://orcid.org/0000-0002-0590-3693
Hoshikawa, Yoshimasa
Hosaka, Hiroko
Saito, Masahiro
Tsuru, Hirotaka
Kato, Shunsuke
Ihara, Eikichi
Koike, Tomoyuki
Uraoka, Toshio
Kasugai, Kunio
Iwakiri, Katsuhiko
Sifrim, Daniel
Pandolfino, John Erik
Taft, Tiffany H.
Fujiwara, Yasuhiro
,
Tanaka, Fumio
Ominami, Masaki
Ochiai, Tadashi
Yamamoto, Kei
Hisaki, Yuki
Kuribayashi, Shiko
Itami, Hideaki
Yachi, Kazuma
Shuto, Yukihiro
Hata, Yoshitaka
Wada, Masafumi
Izawa, Shinya
Funaki, Yasushi
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 25 November 2024
First Online: 9 December 2024
Declarations
:
: Akinari Sawada: Bristol Myers Squibb (grant).,Daniel Sifrim: Jinshan (speaking, grant, trips), Reckitt Benckiser (speaking, grant, trips).,Tiffany H. Taft: Ayble Health (scientific advisory board), Oak Park Behavioral Medicine LLC (ownership).,John Erik Pandolfino: Medtronic (speaking, consulting, patent, license), Sandhill Scientific/Diversatek (grant), Takeda (speaking), Astra Zeneca (speaking), Torax/Ethicon (speaking, consulting), EndoGastric Solutions (advisory board), Phathom (speaking, consulting).,Yasuhiro Fujiwara: Takeda (speaking), Astra Zeneca (speaking), Astellas (speaking), DaiichiSankyo (speaking), Otsuka (speaking), EA Pharma (speaking).The remaining authors declare no conflicts of interest in this study.
